Active substance (DCI)
- chlorhydrate d’irinotécan trihydraté
Technical information
Manufacturer
ACCORD HEALTHCARE FRANCE SAS
Presentation
IRINOTECAN ACCORD 20 mg/mL, solution à diluer pour perfusion
1 flacon (verre brun de type I) de 50 mL (CIP : 34009 550 725 2 2)
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
BGTzXHLYz6h9GUZj
Listen
Français